The correction of pathological acetylation state in the SOD1(G93A) ALS model has been achieved by the synergistic combination of resveratrol with the class I HDAC inhibitors MS-275 and VPA (Schiaffino et al., 2018; Bankole et al., 2022). Here, HDAC9 is linked to amyotrophic lateral sclerosis.